Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Bivalirudin Monitoring By Dilute Thrombin Time Is Cost-Efficient in Pediatric ECMO Patients

Lisa Dorn, Elissa Engel, Tanya Perry, Lori Luchtman-Jones

Blood (2024) 144 (Supplement 1): 5018.

https://doi.org/10.1182/blood-2024-207404

Published: 2024

Journal Articles

Use of a Calibrated, Drug-Specific DTT Assay to Improve Bivalirudin Monitoring in Pediatric Extracorporeal Membrane Oxygenation (ECMO)

Elissa Engel, Tanya Perry, Lori Luchtman-Jones

Blood (2022) 140 (Supplement 1): 8518–8519.

https://doi.org/10.1182/blood-2022-165404

Published: 2022

Journal Articles

Do Family History Questions Improve the Predictive Value of a Standardized Pediatric Bleeding Assessment Tool?

Kelly Bajorek, Matthew Martin, Joseph S. Palumbo, Cristina Tarango, Eric S. Mullins, Lori Luchtman-Jones

Blood (2021) 138 (Supplement 1): 2111.

https://doi.org/10.1182/blood-2021-147051

Published: 2021

Journal Articles

Use of Bivalirudin-Specific Monitoring Assays in Ventricular Assist Device Patients

Elissa Engel, Michael Losos, Janine Martin, Joseph S. Palumbo, Angela Lorts, Rebecca Geer, Lori Luchtman-Jones

Blood (2021) 138 (Supplement 1): 3236.

https://doi.org/10.1182/blood-2021-148028

Published: 2021

Journal Articles

Use of Serum Antiopoietin-2 Assay for Therapeutic Decision-Making in Patients with Vascular Anomalies

Elissa Engel, Kiersten Ricci, Adrienne M Hammill, Karen Mittermeier, Timothy D. LeCras, Lori Luchtman-Jones

Blood (2021) 138 (Supplement 1): 4929.

https://doi.org/10.1182/blood-2021-148011

Published: 2021

Journal Articles

Results of the International Survey on Adherence with Anticoagulation in Children, Adolescents and Young Adults

Courtney D Thornburg, Kevin E Todd, Jr., Meghan E Mcgrady, Vera Ignjatovic, Sophie Jones, Mattia Rizzi, Lori Luchtman-Jones

Blood (2021) 138 (Supplement 1): 5001.

https://doi.org/10.1182/blood-2021-148927

Published: 2021

Journal Articles

Assessing Barriers to Medication Adherence in Pediatric and Adolescent and Young Adult (AYA) Patients on Anticoagulation

Kevin E Todd, Jr., MD, Meghan E Mcgrady, PhD, Anne Blackmore, RN, Carrie Hennessey, RN, Lori Luchtman-Jones, MD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-139660

Published: 2020

Journal Articles

Comparison of Low Molecular Weight Heparin Activity Assays with and without Addition of Exogenous Antithrombin in a Pediatric and Young Adult Leukemia Cohort

Beverly Schaefer, MD, Adriane Hausfeld, Paul Steele, MD, Jan Martin, Sandra Brannon, Adam Lane, PhD, Lori Luchtman-Jones, MD

Blood (2019) 134 (Supplement_1): 4915.

https://doi.org/10.1182/blood-2019-123716

Published: 2019

Journal Articles

Hydroxyurea Pharmacokinetic Profiles in Children Treated for Extreme Thrombocytosis after Total Pancreatectomy with Islet Cell Autotransplant Demonstrate Poor Absorption

Alexander A Boucher, MD, Min Dong, PhD, Anu Marahatta, PhD, Adriane Hausfeld, Thad A. Howard, MS, Jaimie D Nathan, MD, Alexander A. Vinks, PharmD, PhD FCP, Patrick T. McGann, MD, Russell E. Ware, MD PhD, Lori Luchtman-Jones, MD

Blood (2019) 134 (Supplement_1): 4893.

https://doi.org/10.1182/blood-2019-127378

Published: 2019

Journal Articles

Impact of a Standardized Hydroxyurea Dose Regimen for Extreme Thrombocytosis in Children after Pancreatectomy with Islet Autotransplantation

Alexander A Boucher, MD, Todd M. Jenkins, PhD MPH, Lori Luchtman-Jones, MD, Joseph S. Palumbo, MD, Tom K Lin, MD, Maisam Abu-El-Haija, MD, Jaimie D Nathan, MD

Blood (2018) 132 (Supplement 1): 2529.

https://doi.org/10.1182/blood-2018-99-117205

Published: 2018

Journal Articles

Comparison of Multiple Electrode Impedance-Based Platelet Aggregometry to Light Transmission Aggregometry for Diagnosis of Qualitative Platelet Defects

Eric S. Mullins, MD, Davis Stroop, PhD, David Ingala, Cristina Tarango, MD, Lori Luchtman-Jones, MD, Adam Lane, Ralph A. Gruppo, MD

Blood (2017) 130 (Supplement 1): 1048.

https://doi.org/10.1182/blood.V130.Suppl_1.1048.1048

Published: 2017

Journal Articles

Plasminogen Activator Inhibitor Type 1 (PAI-1) and Thrombophilia: A 10 Year Retrospective Review of Clinical Data at a Large Children's Hospital

Triston Burnham, Joseph S. Palumbo, MD, Jennifer Pomales, RN, BSN, NE-BC, CPHON, Adam Lane, Rachel Brockhage, Kejian Zhang, MD MBA, Lori Luchtman-Jones, MD

Blood (2017) 130 (Supplement 1): 1069.

https://doi.org/10.1182/blood.V130.Suppl_1.1069.1069

Published: 2017

Journal Articles

Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial

Russell E. Ware, MD PhD, Adam Lane, PhD, William H Schultz, MHS PA, Hamayun Imran, MD, Margaret T. Lee, MD, Matthew M Heeney, MD, Clark Brown, MD PhD, Lori Luchtman-Jones, MD, Jennifer Webb, MD, Sherron Jackson, MD, Banu Aygun, MD, Scott T. Miller, MD, Jennifer A Rothman, MD, Alexis A. Thompson, MD MPH, Judy Luden, CCRP, Barry R Davis, MD PhD, Robert J. Adams, MD

Blood (2016) 128 (22): 1019.

https://doi.org/10.1182/blood.V128.22.1019.1019

Published: 2016

Journal Articles

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Russell E. Ware, MD PhD, Barry R Davis, MD PhD, William H Schultz, MHS PA, Clark Brown, MD PhD, Banu Aygun, MD, Sharada A. Sarnaik, MD, Isaac Odame, MD, Beng Fuh, MD, Alex George, MD, PhD, William Owen, MD, Lori Luchtman-Jones, MD, Zora R. Rogers, MD, Lee Hilliard, MD, Cynthia Gauger, MD, Connie M. Piccone, MD, Margaret T. Lee, MD, Janet Kwiatkowski, MD, Sherron Jackson, MD, Scott T. Miller, MD, Carla W Roberts, MD, Matthew M. Heeney, MD FRCP(C), Theodosia A. Kalfa, MD PhD, Stephen C Nelson, MD, Hamayun Imran, MD, Kerri A Nottage, MD MPH, Ofelia A. Alvarez, MD, Melissa Rhodes, MD, Alexis A. Thompson, MD, Jennifer Rothman, MD, Kathleen J. Helton, MD, Donna Roberts, MD, Jamie Coleman, MD, Melanie J Bonner, PhD, Abdullah Kutlar, MD, Niren Patel, MD, John C Wood, MD PhD, Linda Piller, MD, Peng Wei, PhD, Judy Luden, CCRP, Nicole A. Mortier, MHS, PA-C, Susan Stuber, MA, Naomi L.C. Luban, MD, Alan R. Cohen, MD, Sara L Pressel, MS, Robert J. Adams, MD MS

Blood (2015) 126 (23): 3.

https://doi.org/10.1182/blood.V126.23.3.3

Published: 2015

Journal Articles

Extrahepatic Iron Deposition In Chronically Transfused Children With Sickle Cell Anemia – Baseline Findings From The Twitch Trial

John C. Wood, MD, PhD, Alan Cohen, MD, Banu Aygun, MD, Hamayun Imran, MD, MSc, Lori Luchtman-Jones, MD, Alexis A. Thompson, MD, MPH, Beng Fuh, MD, Barry R Davis, MD, PhD, Sara L. Pressel, MS, William Herbert Schultz, PA-C, Russell E. Ware, MD, PhD

Blood (2013) 122 (21): 2238.

https://doi.org/10.1182/blood.V122.21.2238.2238

Published: 2013

Journal Articles

Effects of Hydroxyurea (HU) On Lymphocyte Subsets and the Immune Response to Pneumococcal, Measles, Mumps and Rubella Vaccination in the Pediatric Hydroxyurea Phase III Clinical Trial - BABY HUG - (ClinicalTrials.gov Identifier: NCT00006400)

Howard M. Lederman, MD, PhD, Margaret A. Connolly, PhD, Ram Kalpatthi, MD, Russell E. Ware, MD, PhD, Winfred C. Wang, MD, Lori Luchtman-Jones, MD, Myron Waclawiw, PhD, Jonathan C. Goldsmith, MD, James F. Casella, MD

Blood (2012) 120 (21): 243.

https://doi.org/10.1182/blood.V120.21.243.243

Published: 2012

Journal Articles

Prediction of Fetal Hemoglobin in Sickle Cell Anemia Using a Genetic Risk Score

Jacqueline N Milton, MS, Paola Sebastiani, PhD, Clinton T. Baldwin, PhD, Efthymia Melista, Victor R. Gordeuk, MD, Mehdi Nouraie, PhD, Gregory J. Kato, M.D., Caterina Minniti, MD, James G. Taylor, M.D., Andrew Campbell, MD, Lori Luchtman-Jones, MD, Sohail R. Rana, MD, Oswaldo L Castro, MD, Yingze Zhang, PhD, Mark T Gladwin, MD, Martin H. Steinberg, MD

Blood (2012) 120 (21): 3216.

https://doi.org/10.1182/blood.V120.21.3216.3216

Published: 2012

Journal Articles

Genetic Determinants of Hemolysis in Sickle Cell Anemia.

Blood (2012) 120 (21): 2104.

https://doi.org/10.1182/blood.V120.21.2104.2104

Published: 2012

Journal Articles

Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans

Blood (2012) 120 (9): 1961–1962.

https://doi.org/10.1182/blood-2012-06-432849

Published: 2012

Journal Articles

The Physiological and Clinical Effects of Interrupting a Treatment Regimen of Hydroxyurea in Young Children with Sickle Cell Anemia (SCA)

Bruce W Thompson, PhD, Winfred C Wang, MD, Scott T. Miller, MD, Zora R. Rogers, MD, Russell E. Ware, MD, PhD, Courtney D. Thornburg, MD, MS, Sohail R. Rana, MD, Lori Luchtman-Jones, MD, Rathi V. Iyer, MD, James F. Casella, MD

Blood (2011) 118 (21): 2134.

https://doi.org/10.1182/blood.V118.21.2134.2134

Published: 2011

NARROW

Bivalirudin Monitoring By Dilute Thrombin Time Is Cost-Efficient in Pediatric ECMO Patients

Use of a Calibrated, Drug-Specific DTT Assay to Improve Bivalirudin Monitoring in Pediatric Extracorporeal Membrane Oxygenation (ECMO)

Do Family History Questions Improve the Predictive Value of a Standardized Pediatric Bleeding Assessment Tool?

Use of Bivalirudin-Specific Monitoring Assays in Ventricular Assist Device Patients

Use of Serum Antiopoietin-2 Assay for Therapeutic Decision-Making in Patients with Vascular Anomalies

Results of the International Survey on Adherence with Anticoagulation in Children, Adolescents and Young Adults

Assessing Barriers to Medication Adherence in Pediatric and Adolescent and Young Adult (AYA) Patients on Anticoagulation

Comparison of Low Molecular Weight Heparin Activity Assays with and without Addition of Exogenous Antithrombin in a Pediatric and Young Adult Leukemia Cohort

Hydroxyurea Pharmacokinetic Profiles in Children Treated for Extreme Thrombocytosis after Total Pancreatectomy with Islet Cell Autotransplant Demonstrate Poor Absorption

Impact of a Standardized Hydroxyurea Dose Regimen for Extreme Thrombocytosis in Children after Pancreatectomy with Islet Autotransplantation

Comparison of Multiple Electrode Impedance-Based Platelet Aggregometry to Light Transmission Aggregometry for Diagnosis of Qualitative Platelet Defects

Plasminogen Activator Inhibitor Type 1 (PAI-1) and Thrombophilia: A 10 Year Retrospective Review of Clinical Data at a Large Children's Hospital

Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Extrahepatic Iron Deposition In Chronically Transfused Children With Sickle Cell Anemia – Baseline Findings From The Twitch Trial

Effects of Hydroxyurea (HU) On Lymphocyte Subsets and the Immune Response to Pneumococcal, Measles, Mumps and Rubella Vaccination in the Pediatric Hydroxyurea Phase III Clinical Trial - BABY HUG - (ClinicalTrials.gov Identifier: NCT00006400)

Prediction of Fetal Hemoglobin in Sickle Cell Anemia Using a Genetic Risk Score

Genetic Determinants of Hemolysis in Sickle Cell Anemia.

Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans

The Physiological and Clinical Effects of Interrupting a Treatment Regimen of Hydroxyurea in Young Children with Sickle Cell Anemia (SCA)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only